Your browser doesn't support javascript.
loading
Achieving equal and timely access to innovative anticancer drugs in the European Union (EU): summary of a multidisciplinary CECOG-driven roundtable discussion with a focus on Eastern and South-Eastern EU countries.
Wilking, Nils; Bucsics, Anna; Kandolf Sekulovic, Lidlija; Kobelt, Gisela; Laslop, Andrea; Makaroff, Lydia; Roediger, Alexander; Zielinski, Christoph.
Afiliação
  • Wilking N; Karolinska Institute, Stockholm, Sweden.
  • Bucsics A; Mechanism of Coordinated Access to Orphan Medicinal Products, Vienna, Austria.
  • Kandolf Sekulovic L; Department of Dermatology, Faculty of Medicine, Military Medical Academy, Belgrade, Serbia.
  • Kobelt G; European Health Economics AB, Lund, Sweden.
  • Laslop A; Scientific Office, Austrian Federal Office for Safety in Health Care, Vienna, Austria.
  • Makaroff L; Fight Bladder Cancer, Chinnor, United Kingdom and World Bladder Cancer Patient Coalition, Brussels, Belgium.
  • Roediger A; EFPIA Oncology Platform, Brussels, Belgium and Oncology Policy Europe, Middle East, Africa and Canada, MSD, Kriens, Switzerland.
  • Zielinski C; Central European Cooperative Oncology Group (CECOG) and Vienna Cancer Center, Vienna Hospital Association, Vienna, Austria.
ESMO Open ; 4(6): e000550, 2019.
Article em En | MEDLINE | ID: mdl-31798977
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Eixos temáticos: Inovacao_tecnologica Base de dados: MEDLINE Assunto principal: Drogas em Investigação / Aprovação de Drogas / Cooperação Internacional / Oncologia / Neoplasias / Antineoplásicos Tipo de estudo: Health_technology_assessment / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Eixos temáticos: Inovacao_tecnologica Base de dados: MEDLINE Assunto principal: Drogas em Investigação / Aprovação de Drogas / Cooperação Internacional / Oncologia / Neoplasias / Antineoplásicos Tipo de estudo: Health_technology_assessment / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article